Exercise or conversion
Martine A. Rothblatt
Chairperson & CEO
Common Stock
- Value context
- $1.12M
- Reported price
- $117.76 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
UNITED THERAPEUTICS Corp
Last 30 daysNo qualifying insider buying. Sales: $114.49M by 3 insiders.
Showing the first 6 of 2332 trades on this page.
Chairperson & CEO
Common Stock
Chairperson & CEO
Common Stock
No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.